Resumen de Boom in gene-editing clinical trials
The CRISPR genome editing revolution continues to advance at an astounding pace. As many as 20 human trials will be under way soon, mostly in China, New Scientist has learned. One of these trials will involve the first-ever attempt to edit cells while they are inside the body. The aim is to prevent cervical cancers by using CRISPR to target and destroy the genes of the human papillomavirus that cause tumor growth. This study is due to begin in July at the First Affiliated Hospital of Sun Yat-Sen University in China
